Potential Gene Therapy Safely Restores FVIII Clotting Factor in Animals and Human Cells, ASC Therapeutics Reports
A gene therapy being developed by ASC Therapeutics restored levels of the clotting factor missing…
Articles by Alejandra Viviescas, PhD
Advate is Safe, Effective Therapy for Hemophilia A, Japanese Study Finds
Advate is an effective and well-tolerated treatment among patients with hemophilia A, according to an observational, long-term, Japanese study. The treatment…
Low Doses of Feiba Cut Risk of Relapse After Acute Bleeding Events in Acquired Hemophilia A, Study Says
Administering low doses of Feiba, or activated prothrombin complex concentrate (aPCC), as a prophylactic (preventive) treatment after acute bleeding events…
Researchers Recommend Changes to Protocol in Novoseven/Feiba Combo Therapy
Combining the bypassing agents Novoseven and Feiba, with extended time between doses, could be a successful and cost-effective protocol to…
BIVV001 Increases Half-life of Factor VIII in People with Severe Hemophilia A, Phase 1/2a Trial Shows
A single dose of BIVV001Â significantly increased levels of factor VIII for a week in the blood of people with severe…